Market Cap
Merck & Co., Inc.
$318.75 Billion
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Johnson & Johnson | $350.63 B |
AbbVie | $295.34 B |
AstraZeneca | $236.45 B |
Novartis | $219.78 B |
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
AbbVie | $295.34 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Merck & Company, Inc., known as Merck Sharp & Dohme, or MSD, outside the United States and Canada, is one of the largest pharmaceutical companies in the world. Founded in 1891 in the US, and independent since World War I from its parent company, now one of the largest companies in Germany, Merck provides prescription medicines, vaccines, biologic therapies, and animal health products.
Merck & Co., Inc. has the following listings and related stock indices.
Stock: NYSE: MRK
Stock: FSX: 6MK
Stock: Euronext: MRK
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.